Durvalumab-Induced Triple-M Syndrome.

Eur J Case Rep Intern Med · 2024 · PMC11313117 · PMID 39130070

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A systematic review of cases showed a trend in favour of early onset with a median time of symptom onset within the first cycle [ 2 ] .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.